Biocon and Mylan launch first Insulin Glargine Biosimilar, Semglee, in Australia
Biocon Ltd and Mylan N V on Thursday announced the launch of Semglee (insulin glargine solution for injection 100 IU/mL in a 3mL pre-filled pen), the first insulin glargine biosimilar …
Biocon and Mylan launch first Insulin Glargine Biosimilar, Semglee, in Australia Read More